FDA's standardized labeling initiative should get Congressional review, HIMA maintains.
DEVICE STANDARDIZED LABELING POLICY SUBJECT TO REVIEW BY CONGRESS, HIMA MAINTAINS in Oct. 30 comments to FDA on the agency's draft guidance document on standardized medical device labeling. "Before the draft labeling guidance can be put into effect, the agency must comply with" the Small Business Regulatory Enforcement Fairness Act of 1996 by submitting the proposed policy to Congress for approval, the Health Industry Manufacturers Association asserts.